Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Maximiliano Servín-Rojas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3388-3930; OpenAlex author ID A5047753543. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2023: 1 paper · 2024: 3 papers · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Lymph Node Yield Is Associated With Improved Overall Survival and Increased Time to Recurrence in Node-Negative Pancreatic Ductal Adenocarcinoma Following Neoa… Co-author DOI 10.1097/sla.0000000000006432↗
  2. Preoperative Biopsy Is Not Associated With Adverse Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Upfront Resection. Co-author DOI 10.1016/j.jss.2025.01.007↗
  3. Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.surg.2023.09.041↗
  4. The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national re… First author DOI 10.1016/j.surg.2023.11.004↗
  5. Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000006131↗
  6. Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pancreatic cancer. Co-author DOI 10.1016/j.hpb.2023.04.010↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Motaz Qadan · 6 shared papers, 2023–2026 · strength 1.36
  2. Keith D. Lillemoe · 5 shared papers, 2024–2026 · strength 1.12
  3. Zhi Ven Fong · 4 shared papers, 2024–2026 · strength 0.95
  4. Louisa Bolm · 4 shared papers, 2024–2026 · strength 0.91
  5. Cristina Rosa Ferrone · 3 shared papers, 2024–2026 · strength 0.67
  6. Carlos Fernández-del Castillo · 2 shared papers, 2025–2026 · strength 0.57
  7. Carlos F. Fernandez-del Castillo · 2 shared papers, 2024 · strength 0.38
  8. Guoliang Qiao · 2 shared papers, 2024 · strength 0.38
  9. Gabriella Lionetto Lionetto · 1 shared paper, 2026 · strength 0.29
  10. Naomi M. Sell · 1 shared paper, 2023 · strength 0.24
  11. Fidel López‐Verdugo · 1 shared paper, 2024 · strength 0.21
  12. Tobias Keck · 1 shared paper, 2024 · strength 0.17
  13. Hryhoriy V. Lapshyn · 1 shared paper, 2024 · strength 0.17
  14. Thaer S. A. Abdalla · 1 shared paper, 2024 · strength 0.17
  15. Rüdiger Braun · 1 shared paper, 2024 · strength 0.17
  16. Steffen Deichmann · 1 shared paper, 2024 · strength 0.17
  17. Kim C. Honselmann · 1 shared paper, 2024 · strength 0.17
  18. Ulrich Friedrich Wellner · 1 shared paper, 2024 · strength 0.17
  19. Natalie Petruch · 1 shared paper, 2024 · strength 0.17
  20. Theodore Sunki Hong · 1 shared paper, 2024 · strength 0.17
  21. Kelsey S. Lau‐Min · 1 shared paper, 2024 · strength 0.17
  22. Hannah Johnson Roberts · 1 shared paper, 2024 · strength 0.17
  23. Priyadarshini Pathak · 1 shared paper, 2024 · strength 0.17
  24. David P. Ryan · 1 shared paper, 2024 · strength 0.17
  25. Lawrence Scott Blaszkowsky · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.